Gene Therapy Of The Human Retina Stocks List

	Symbol	Grade	Name	% Change
	ADVM	D	Adverum Biotechnologies, Inc.	1.58
	FDMT	F	4D Molecular Therapeutics, Inc.	1.06

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
LABD	D	Direxion Daily S&P Biotech Bear 3X Shares	0.55
HELX	D	Franklin Genomic Advancements ETF	0.44
IDNA	C	iShares Genomics Immunology and Healthcare ETF	0.4
SBIO	B	ALPS Medical Breakthroughs ETF	0.27
BBC	B	Virtus LifeSci Biotech Clinical Trials ETF	0.26

Compare ETFs

Compare HELX to SBIO Compare IDNA to BBC Compare SBIO to BBC

Date	Stock	Title
Oct 30	FDMT	We're Hopeful That 4D Molecular Therapeutics (NASDAQ:FDMT) Will Use Its Cash Wisely

Gene Therapy Of The Human Retina: Gene therapy of the human retina is a form of gene therapy that involves introducing healthy genes into the cells of the retina in order to treat or prevent certain diseases or disorders of the eye. This type of therapy is used to treat conditions such as retinitis pigmentosa, age-related macular degeneration, and Leber congenital amaurosis. The goal of gene therapy is to replace the defective gene with a healthy gene, allowing the cells of the retina to function normally.